Position in VRTX
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$214,339
-$88,842 QoQ
Shares Held
480
-29.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EWA, LLC holds $516,245 across 7 Biotechnology names. VRTX ranks #1 (41.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
480 | $214,339 | |
| 2 | CGEN |
Compugen Ltd
|
60,047 | $127,900 | |
| 3 | SLS |
SELLAS Life Sciences Group, Inc.
|
12,796 | $54,127 | |
| 4 | TLSA |
Tiziana Life Sciences Ltd
|
45,948 | $53,759 | |
| 5 | CCCC |
C4 Therapeutics, Inc.
|
14,572 | $38,324 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
28,680 | $19,846 | |
| 7 | RANI |
Rani Therapeutics Holdings, Inc.
|
10,817 | $7,950 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $214,339 | 480 | Shares | Sole | 2026-04-23 | |
| 2025-06-30 | $303,181 | 681 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $283,134 | 584 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $238,801 | 593 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $260,909 | 561 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $233,891 | 499 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $200,226 | 479 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||